Investigators at the Beaumont Research Institute, part of Beaumont Health in Michigan, are hopeful that their study involving small molecules in saliva will help identify those at risk of developing Alzheimer's disease - a neurologic condition predicted to reach epidemic proportions worldwide by 2050. Their study, "Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics" was published in the Journal of Alzheimer's Disease. Investigators found salivary molecules hold promise as reliable diagnostic biomarkers. Investigators seek to develop valid and reliable biomarkers, diagnosing the disease in its earliest stages before brain damage occurs and dementia begins. Researcher Stewart Graham, Ph.D., said, "We used metabolomics, a newer technique to study molecules involved in metabolism. Metabolomics is used in medicine and biology for the study of living organisms. "Given the ease and convenience of collecting saliva, the development of accurate and sensitive biomarkers would be ideal for screening those at greatest risk of developing Alzheimer's. Dr. Graham said, "Worldwide, the development of valid and reliable biomarkers for Alzheimer's disease is considered the No. 1 priority for most national dementia strategies. The condition's toll not only affects millions of Americans, but in 2017, it could cost the nation $259 billion.
People with pre-existing medical conditions, such as heart disease or diabetes, will be taken care of under the replacement plan for Obamacare, President Trump has promised.
But that plan, called the American Health Care Act, which passed the House of Representatives earlier this month, could strand people who have pre-existing conditions with health insurance that has high premiums and skimpy coverage.
That’s on top of the higher premiums and deductibles that the law would create for everybody buying insurance on their own.
Here’s how that would work.
1. Insurance companies would still have to sell coverage to sick people, but they could charge very high premiums for it. Under the AHCA, insurance companies could go back to the pre-Obamacare practice of underwriting premiums, meaning they could charge people different amounts depending on their health history. That would mean low premiums for healthy people and high premiums for people with pre-existing conditions.
There would be no limit on how much they could jack up premiums for people with expensive conditions and it would be up to the insurance companies to decide what pre-existing conditions they don’t like. This would be especially painful because the AHCA also reduces the government subsidies that help lower-income people pay for health insurance.
The AHCA gives sick people a theoretical out: It says that if you don’t let your insurance lapse, you can stay in the “community rated” risk pool, where…